ArticlePharmaceutics2023

Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose.

Daniele Veritti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.